Finecare™ 2019-nCoV RBD Test
RBD (receptor binding domain) of
2019-nCoV virus S1 protein is the
region that binds to the ACE2
receptor on human cells as the first
step of virus invading.
The Finecare™ 2019-nCoV RBD Antibody Test is a fluorescence immunoassay used along with Finecare™ FIA Meters for qualitative and semi-quantitative detection of spike receptor-binding domain (RBD) antibodies of novel coronaviruses (2019-nCoV) in human fingerstick whole blood, venipuncture whole blood, serum or plasma specimen.
The 2019-nCoV RBD antibodies are protective antibody produced by the human body after inoculation with 2019-nCoV vaccine or infection with 2019-nCoV. The test is intended as an aid to assess the adaptive humoral immune response to the 2019-nCoV RBD protein.
For in vitro diagnostic use only. For professional use only.
STORAGE AND STABILITY
1. Store at 4~30°C in the sealed pouch up to the expiration date printed on the package. Do not freeze.
2. The test device should be used within 1 hour after taking out from the foil envelope.
3. Keep away from sunlight, moisture and heat.
4. Kit contents are stable until the expiration date printed on the outer box.
|| Test Result Interpretation
||Neutralizing antibodies for 2019-nCoV are not detected at 50% virus neutralization
||Positive (Low titer)
||Low neutralizing antibodies for 2019-nCoV are detected at 50% virus neutralization.
||Positive (High titer)
||High neutralizing antibodies for 2019-nCoV are detected at 50% virus neutralization.
||Fingerstick whole blood,
venipuncture whole blood,
serum or plasma
Get Free Quote Now
If you’re interested in our products or service, please leave your information here, and we will be in touch with you shortly.